{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:18:55Z","timestamp":1788520735408,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ando.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T20:54:31Z","timestamp":1651697671000},"page":"164-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mild hyperprolactinemia in a couple: What impact on fertility?"],"prefix":"10.1016","volume":"83","author":[{"given":"Dominique","family":"Maiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2022.04.002_bib0215","first-page":"hoab026","article-title":"European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE) ART in Europe 2017, results generated from European registries by ESHRE","volume":"3","author":"Wyns","year":"2021","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.ando.2022.04.002_bib0220","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.04.002_bib0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2015.36","article-title":"New insights in prolactin: pathological implications","volume":"11","author":"Bernard","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2022.04.002_bib0230","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1210\/en.2010-1225","article-title":"Kisspeptin is essential for the full preovulatory LH surge and stimulates GnRH release from the isolated ovine median eminence","volume":"152","author":"Smith","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2022.04.002_bib0235","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1172\/JCI63937","article-title":"Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration","volume":"122","author":"Sonigo","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2022.04.002_bib0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(76)91343-X","article-title":"Hyperprolactinemia and luteal insufficiency","volume":"1","author":"Seppala","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2022.04.002_bib0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.04.002_bib0250","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/REP-06-0299","article-title":"Reproductive role of prolactin","volume":"133","author":"Bachelot","year":"2007","journal-title":"Reproduction"},{"key":"10.1016\/j.ando.2022.04.002_bib0255","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/290600a0","article-title":"Prolactin inhibits oestrogen synthesis in the ovary","volume":"290","author":"Dorrington","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.ando.2022.04.002_bib0260","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jcem-54-6-1246","article-title":"Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary","volume":"54","author":"Demura","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.04.002_bib0265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/250653a0","article-title":"A possible role for prolactin in control of steroid secretion by the human Graafian follicle","volume":"250","author":"McNatty","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.ando.2022.04.002_bib0270","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-017-1438-7","article-title":"Prolactinoma through the female life cycle","volume":"59","author":"Cocks Eschler","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2022.04.002_bib0275","doi-asserted-by":"crossref","first-page":"594370","DOI":"10.3389\/fendo.2020.594370","article-title":"The interplay between prolactin and reproductive system: focus on uterine pathophysiology","volume":"11","author":"Auriemma","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2022.04.002_bib0280","first-page":"651","article-title":"Transient hyperprolactinemia in infertile women with luteal phase deficiency","volume":"78","author":"Huang","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ando.2022.04.002_bib0285","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0002-9378(83)90441-6","article-title":"Human myometrium: a new potential source of prolactin","volume":"147","author":"Walters","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ando.2022.04.002_bib0290","first-page":"225","article-title":"Prolactin concentration in various stages of endometriosis in infertile women","volume":"23","author":"Mirabi","year":"2019","journal-title":"JBRA Assist Reprod"},{"key":"10.1016\/j.ando.2022.04.002_bib0295","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s11102-013-0497-x","article-title":"Male prolactinomas presenting with normal testosterone levels","volume":"17","author":"Shimon","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2022.04.002_bib0300","series-title":"Prolactin disorders From basic science to clinical management.","first-page":"189","article-title":"Prolactinomas in men","author":"Maiter","year":"2019"},{"key":"10.1016\/j.ando.2022.04.002_bib0305","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2003-030979","article-title":"Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis","volume":"89","author":"Colao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.04.002_bib0310","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2265.2006.02461.x","article-title":"The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males","volume":"64","author":"De Rosa","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2022.04.002_bib0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0303-7207(87)90098-0","article-title":"Prolactin and antiprolactin receptor antibody inhibit steroidogenesis by purified rat Leydig cells in culture","volume":"52","author":"Barkey","year":"1987","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2022.04.002_bib0320","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0015-0282(98)00164-2","article-title":"Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials","volume":"70","author":"Hirahara","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2022.04.002_bib0325","series-title":"Recent advances in medically assisted conception number 820","first-page":"1","author":"WHO Technical Report Series","year":"1992"},{"key":"10.1016\/j.ando.2022.04.002_bib0330","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.fertnstert.2009.12.017","article-title":"Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility","volume":"94","author":"Souter","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2022.04.002_bib0335","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cen.13156","article-title":"The epidemiology of hyperprolactinemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS)","volume":"86","author":"Soto-Pedre","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2022.04.002_bib0340","doi-asserted-by":"crossref","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.04.002_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0011-5029(82)90628-9","article-title":"Hyperprolactinemic disorders","volume":"28","author":"Molitch","year":"1982","journal-title":"Disease-A-Month"},{"key":"10.1016\/j.ando.2022.04.002_bib0350","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-014-0576-7","article-title":"Importance of cannulated prolactin test in the definition of hyperprolactinemia","volume":"18","author":"Whyte","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2022.04.002_bib0355","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2013.07.002","article-title":"Determination of prolactin: the macroprolactine problem","volume":"27","author":"Fahie-Wilson","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.04.002_bib0360","doi-asserted-by":"crossref","DOI":"10.1177\/1179558119871921","article-title":"PCOS and Hyperprolactinemia: what do we know in 2019?","volume":"13","author":"Delcour","year":"2019","journal-title":"Clin Med Insights Reprod Health"},{"key":"10.1016\/j.ando.2022.04.002_bib0365","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-017-1438-7","article-title":"Prolactinoma through the female life cycle","volume":"59","author":"Cocks Eschler","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2022.04.002_bib0370","first-page":"1039","article-title":"Reproductive function and pregnancy outcomes in women treated for idiopathic hyperprolactinemia: A non-randomized controlled study","volume":"18","author":"Sokhadze","year":"2020","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.ando.2022.04.002_bib0375","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ando.2016.04.001","article-title":"Prolactinoma and pregnancy: From the wish of conception to lactation","volume":"77","author":"Maiter","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2022.04.002_bib0380","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-21-0462","article-title":"ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy","volume":"185","author":"Luger","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.04.002_bib0385","first-page":"CD008883","article-title":"Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history","volume":"7","author":"Chen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ando.2022.04.002_bib0390","doi-asserted-by":"crossref","unstructured":"Bussen S, S\u00fctterlin M, Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod 199;14:18-20","DOI":"10.1093\/humrep\/14.1.18"},{"key":"10.1016\/j.ando.2022.04.002_bib0395","doi-asserted-by":"crossref","first-page":"314","DOI":"10.14310\/horm.2002.1505","article-title":"Hormonal causes of recurrent pregnancy loss (RPL)","volume":"13","author":"Pluchino","year":"2014","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.ando.2022.04.002_bib0400","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2016.02.015","article-title":"Coll\u00e8ge National des Gyn\u00e9cologues Obst\u00e9triciens Fran\u00e7ais. Pregnancy loss: French clinical practice guidelines","volume":"201","author":"Huchon","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ando.2022.04.002_bib0405","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fendo.2020.00584","article-title":"Mildly higher serum prolactin levels are directly proportional to cumulative pregnancy outcomes in in-vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2022.04.002_bib0410","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/09513590009167716","article-title":"Treatment versus no treatment of transient hyperprolactinemia in patients undergoing intracytoplasmic sperm injection programs","volume":"14","author":"Doldi","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ando.2022.04.002_bib0415","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2005.06.002","article-title":"EAU Guidelines on male infertility","volume":"48","author":"Dohle","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ando.2022.04.002_bib0420","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11934-016-0612-4","article-title":"Hormone-based treatments in subfertile males","volume":"17","author":"Patel","year":"2016","journal-title":"Curr Urol Rep"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662200049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662200049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:52:52Z","timestamp":1757717572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000342662200049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S000342662200049X"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2022.04.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mild hyperprolactinemia in a couple: What impact on fertility?","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}